Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02737917 · ClinicalTrials.gov registry record · NA
EmergeNcy Department Apneic Oxygenation Versus Usual Care During Rapid Sequence Intubation
A NA study of Diffuse Apneic Oxygenation, sponsored by New York City Health and Hospitals Corporation.
- Completed
- Registry status
- NA
- Development phase
- 206
- Enrollment target
- 1
- Study location
NCT02737917 is a NA study of Diffuse Apneic Oxygenation that has completed, run by New York City Health and Hospitals Corporation. The registered enrollment target is 206 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02737917, a NA study of Diffuse Apneic Oxygenation, has completed, sponsored by New York City Health and Hospitals Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 206 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the impact, if any the application of oxygen during the apnea period of rapid sequence intubation has on patients being intubated in the emergency department.
Conditions Studied
Interventions
- OTHER Standard of care
- OTHER Oxygen
Study Locations (1)
New York
- Lincoln Medical Center - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 206 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02737917
The ClinicalTrials.gov registry entry for NCT02737917 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 206 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York City Health and Hospitals Corporation, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diffuse Apneic Oxygenation appearing as the primary indexed condition, and to 2 interventions - of which Standard of care is the first listed.
NCT02737917 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT02737917 about?
NCT02737917 is a clinical study titled "EmergeNcy Department Apneic Oxygenation Versus Usual Care During Rapid Sequence Intubation". To determine the impact, if any the application of oxygen during the apnea period of rapid sequence intubation has on patients being intubated in the emergency department.
What is the current status of trial NCT02737917?
This trial is currently completed. It is a NA study. The enrollment target is 206 participants. The study started on 2016-05. Estimated completion is 2016-12.
What conditions does trial NCT02737917 study?
This clinical trial studies the following conditions: Diffuse Apneic Oxygenation.
What interventions are being tested in trial NCT02737917?
The interventions under investigation include: Standard of care (OTHER), Oxygen (OTHER).
Who is sponsoring clinical trial NCT02737917?
This trial is sponsored by New York City Health and Hospitals Corporation, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02737917 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.